Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar in Safety and Efficacy to Lantus

Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar in Safety and Efficacy to Lantus
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Insulin | Lantus | Research | Study